Crohn's Disease and Colitis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 18 or older
- People who have been diagnosed with a severe flare-up of ulcerative colitis, assessed using a specific set of medical criteria called the Truelove Witts criteria
- People who received at least one injection of the under-the-skin (subcutaneous) form of Infliximab, after first receiving two or three drip infusions (intravenous) of Infliximab
- People who have been followed up for at least 12 months after their first under-the-skin Infliximab injection
- People whose medical records contain the necessary health information from those 12 months of follow-up
- People who have been fully informed about how this research is organised and have not objected to taking part or to their data being used
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who continued receiving Infliximab as ongoing treatment through a drip infusion (intravenous), rather than switching to the under-the-skin form
- People who switched from drip infusion to under-the-skin Infliximab but received more than three drip infusions before switching
- People who are classified as "protected persons" under applicable regulations (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33383155580
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Treatment failure at 12 months to describe treatment effectiveness
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.